Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by BearDownAZ


T.RVX

RE:RE:RE:Financials & MD&A

Thanks for the summary G1945V. You wrote "Comment: When adding up all of...

March 16, 2019

ESPR

ESPR announces Study 1 & ACYL Genetic Validation NEJM papers

Esperion Announces Publication of Bempedoic Acid Study 1 Results in The New...

March 13, 2019

T.RVX

RE:Question for Bear....

"Is it possible for patients to have their own blood markers done...

March 12, 2019

T.RVX

RE:RE:RE:RE:March 11, 2019 09:00 ET | Source: Resverlogix Corp

Now the webcast is up: Resverlogix will be participating and presenting...

March 11, 2019

T.RVX

RE:RE:March 11, 2019 09:00 ET | Source: Resverlogix Corp

That's not a webcast. Those are slides for March Corporate Update. And...

March 11, 2019

T.RVX

RE:RE:Banded at Agoracom

DNDstocks, I contact Agoracom and you are now re-instated. Welcome back...

March 11, 2019

T.RVX

RE:Banded at Agoracom

DNDstocks, I will look into it. As far as I know it wasn't any of the...

March 11, 2019

V.BTI.H

RE:RE:RE:BioBoss Interview

From the recent xB3 Medimmune paper, reference 21 (unpublished, in revision...

March 5, 2019

ESPR

ESPR to present at ACC 2019

Esperion Announces Presentation of Bempedoic Acid Pivotal Phase 3 Study 2...

March 4, 2019

T.RVX

RE:Trial End

The count announced in November was referencing the count from the September...

March 3, 2019

ESPR

ESPR Corporate Update

Esperion Provides Bempedoic Acid Franchise Development Program Updates...

March 1, 2019

T.RVX

RE:RE:RE:bear

"Now I thought when we spoke this summer bear, that results should have...

March 1, 2019

T.RVX

RE:RE:RE:RE:Just received from Sarah- BOM Queries

G1945V, Yes, it's frustrating to try to interpret the ambiguity and have...

February 28, 2019

ESPR

ESPR Bempedoic Acid NDA and MMA news!

Esperion Announces Submissions of Two NDAs and Official Completion of Two MAA...

February 28, 2019

T.RVX

RE:RE:Just received from Sarah- BOM Queries

"So presumably this single endpoint can be determined in a reasonably...

February 28, 2019

V.BTI.H

RE:Mark Day interview with Stock News Now

Old link not working. Try this one: https://youtu.be/nVdRotBEunM

February 27, 2019

V.BTI.H

Mark Day interview with Stock News Now

SNNLive spoke with Mark Day, Ph.D., President & CEO of Bioasis...

February 27, 2019

T.RVX

RE:Just received from Sarah- BOM Queries

Thanks for sharing that response from Sarah GV. Nearly identical to two...

February 26, 2019

T.RVX

RE:RE:RE:The Time is Ripe for RVX

"What would the results have been if the Placebo Group was not given...

February 25, 2019

T.RVX

RE:The Time is Ripe for RVX

"Love to know the RRR if the data for Amarin is scaled back to account...

February 25, 2019